Zapped assembly of polymeric (ZAP) nanoparticles for anti-cancer drug delivery

被引:10
|
作者
Dunn, Stuart S. [1 ]
Luft, J. Christopher [1 ,2 ,3 ]
Parrott, Matthew C. [1 ,3 ,4 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Div Mol Pharmaceut, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Carolina Inst Nanomed, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Dept Radiol, Biomed Res Imaging Ctr, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
HYBRID NANOPARTICLES; CONTROLLED-RELEASE; CANCER CELLS; SIZE; BIODISTRIBUTION; MECHANISMS; CLEARANCE; EFFICACY; SYSTEMS; SHAPE;
D O I
10.1039/c8nr09944h
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The starting hypothesis for this work was that microwave synthesis could enable the rapid assembly of polymers into size-specific nanoparticles (NPs). The Zapped Assembly of Polymeric (ZAP) NPs was initially realized using poly(lactic-co-glycolic acid)-poly(ethylene glycol) (PLGA-PEG) block copolymers and distinct microwave reaction parameters. A library of polymeric NPs was generated with sizes ranging from sub-20 nm to 350 nm and low polydispersity. Select ZAP NPs were synthesized in 30 seconds at different scales and concentrations, up to 200 mg and 100 mg mL(-1), without substantial size variation. ZAP NPs with diameters of 25 nm, 50 nm, and 100 nm were loaded with the chemotherapeutic paclitaxel (PXL), demonstrated unique release profiles, and exhibited dose-dependent cytotoxicity similar to Taxol. Incorporation of d-alpha tocopheryl polyethylene glycol succinate (TPGS) and PLGA(33k) allowed for the production of a sub-40 nm NP with an exceptionally high loading of PXL (12.6 wt%, ca. 7 times the original NP) and a slower release profile. This ZAP NP platform demonstrated scalable, flexible, and tunable synthesis with potential toward clinical scale production of size-specific drug carriers.
引用
收藏
页码:1847 / 1855
页数:9
相关论文
共 50 条